0001055726-19-000017.txt : 20190312
0001055726-19-000017.hdr.sgml : 20190312
20190312191844
ACCESSION NUMBER: 0001055726-19-000017
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190308
FILED AS OF DATE: 20190312
DATE AS OF CHANGE: 20190312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Humeau Laurent
CENTRAL INDEX KEY: 0001770390
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14888
FILM NUMBER: 19676492
MAIL ADDRESS:
STREET 1: C/O INOVIO PHARMACEUTICALS, INC.
STREET 2: 660 W. GERMANTOWN PIKE, SUITE 110
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001055726
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330969592
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584103134
MAIL ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP
DATE OF NAME CHANGE: 20050404
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP
DATE OF NAME CHANGE: 20011116
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD
DATE OF NAME CHANGE: 19980213
3
1
wf-form3_155243270986430.xml
FORM 3
X0206
3
2019-03-08
0
0001055726
INOVIO PHARMACEUTICALS, INC.
INO
0001770390
Humeau Laurent
C/O INOVIO PHARMACEUTICALS, INC.
6769 MESA RIDGE RD.
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
22201
D
Restricted Stock Unit
2029-03-08
Common Stock
2666.0
D
Restricted Stock Unit
2027-03-10
Common Stock
5624.0
D
Restricted Stock Unit
2028-03-05
Common Stock
53133.0
D
Common Stock Option
10.0
2024-01-06
Common Stock
20000.0
D
Common Stock Option
7.56
2025-03-05
Common Stock
25000.0
D
Common Stock Option
7.02
2026-03-09
Common Stock
18000.0
D
Common Stock Option
6.68
2027-03-10
Common Stock
13750.0
D
Common Stock Option
4.29
2018-03-05
Common Stock
126500.0
D
Each restricted stock unit represents a contingent right to receive one share of common stock. The 2,666 restricted stock vested on March 9, 2019.
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares will vest on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,133 restricted stock units is as follows: 26,567 shares will vest on March 5, 2020; 26,566 shares will vest on March 5, 2021. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
The common stock options will vest over a period of three years, with 25% of the shares underlying the option vesting immediately, and 25% on the first, second, and third anniversaries of the date of grant. The expiration date of this option reported in the table is the day of the tenth anniversary of the grant date of the option.
/s/ Laurent Humeau
2019-03-12